These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 19302316)

  • 1. Incorporating time postinoculation into a dose-response model of Yersinia pestis in mice.
    Huang Y; Bartrand TA; Haas CN; Weir MH
    J Appl Microbiol; 2009 Sep; 107(3):727-35. PubMed ID: 19302316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92.
    Rogers JV; Choi YW; Giannunzio LF; Sabourin PJ; Bornman DM; Blosser EG; Sabourin CL
    Microb Pathog; 2007; 43(2-3):67-77. PubMed ID: 17531433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host.
    Liu H; Wang H; Qiu J; Wang X; Guo Z; Qiu Y; Zhou D; Han Y; Du Z; Li C; Song Y; Yang R
    J Basic Microbiol; 2009 Feb; 49(1):92-9. PubMed ID: 18759226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
    J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague.
    Leary SE; Griffin KF; Galyov EE; Hewer J; Williamson ED; Holmström A; Forsberg A; Titball RW
    Microb Pathog; 1999 Mar; 26(3):159-69. PubMed ID: 10089156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dam mutant of Yersinia pestis is attenuated and induces protection against plague.
    Robinson VL; Oyston PC; Titball RW
    FEMS Microbiol Lett; 2005 Nov; 252(2):251-6. PubMed ID: 16188402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response model for Burkholderia pseudomallei (melioidosis).
    Tamrakar SB; Haas CN
    J Appl Microbiol; 2008 Nov; 105(5):1361-71. PubMed ID: 18778292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental infection of ground squirrels (Citellus pygmaeus Pallas) with Yersinia pestis during hibernation.
    Bizanov G; Dobrokhotova ND
    J Infect; 2007 Feb; 54(2):198-203. PubMed ID: 16580730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fat in ground beef on the growth and virulence plasmid (pYV) stability in Yersinia pestis.
    Bhaduri S
    Int J Food Microbiol; 2010 Jan; 136(3):372-5. PubMed ID: 19875186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.
    Davis KJ; Vogel P; Fritz DL; Steele KE; Pitt ML; Welkos SL; Friedlander AM; Byrne WR
    Arch Pathol Lab Med; 1997 Aug; 121(8):865-8. PubMed ID: 9278616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dose-response models for microbial risk assessment.
    Huang Y; Haas CN
    Risk Anal; 2009 May; 29(5):648-61. PubMed ID: 19187487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
    Tripathi V; Chitralekha KT; Bakshi AR; Tomar D; Deshmukh RA; Baig MA; Rao DN
    Vaccine; 2006 Apr; 24(16):3279-89. PubMed ID: 16476510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
    Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
    Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the lipopolysaccharide of Yersinia pestis.
    Prior JL; Hitchen PG; Williamson DE; Reason AJ; Morris HR; Dell A; Wren BW; Titball RW
    Microb Pathog; 2001 Feb; 30(2):49-57. PubMed ID: 11162185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary genetics: CCR5 mutation and plague protection.
    Mecsas J; Franklin G; Kuziel WA; Brubaker RR; Falkow S; Mosier DE
    Nature; 2004 Feb; 427(6975):606. PubMed ID: 14961112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental model to evaluate the human body louse as a vector of plague.
    Houhamdi L; Lepidi H; Drancourt M; Raoult D
    J Infect Dis; 2006 Dec; 194(11):1589-96. PubMed ID: 17083045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioluminescent imaging of bacteria during mouse infection.
    Warawa JM; Lawrenz MB
    Methods Mol Biol; 2014; 1098():169-81. PubMed ID: 24166377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.